PRL and ovarian cancer: According to a recent study, the simultaneous detection of six biomarkers [leptin, prolactin, osteopontin, insulin-like growth factor II (IGF-II), macrophage inhibitory factor (MIF), and CA125] would have 95% sensitivity and 99% specificity for ovarian cancer, particularly higher than that of CA125 alone.